February 9, 2018
Wilmot Cancer Institute patients with advanced melanoma (stage III) now have more options for treatment, thanks to research co-authored by a University of Rochester Medical Center surgical oncologist and published in Lancet Oncology. The study involved comparing two treatment approaches for high-risk melanoma patients with a BRAF gene mutation in their cancer: standard […]
